Home › Funds › Geode Capital Management › BCLI
Geode Capital Management position in BCLI
BRAINSTORM CELL THERAPEUTICS
Latest position (Q2 2025)54.58K sh
Reported value held$61.14K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 275.75K | $909.00K | New |
| Q4 2021 | 278.10K | $1.11M | Add |
| Q1 2022 | 283.49K | $952.00K | Add |
| Q2 2022 | 275.91K | $761.00K | Reduce |
| Q3 2022 | 276.64K | $1.22M | Hold |
| Q4 2022 | 273.71K | $448 | Reduce |
| Q1 2023 | 275.71K | $909.83K | Add |
| Q2 2023 | 275.71K | $567.95K | Hold |
| Q3 2023 | 310.78K | $62.22K | Add |
| Q4 2023 | 357.04K | $97.51K | Add |
| Q1 2024 | 357.04K | $201.71K | Hold |
| Q2 2024 | 484.29K | $163.99K | Add |
| Q3 2024 | 682.82K | $151.96K | Add |
| Q4 2024 | 52.50K | $119.21K | Reduce |
| Q1 2025 | 58.16K | $73.30K | Add |
| Q2 2025 | 54.58K | $61.14K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.